Case Study 29-APH
Case Study 29-APH
Case Study 29-APH
ANTEPARTUME
HAEMORRHAGE
• Types:
Revealed - Pain + Vaginal bleeding-80%
Concealed - pain/shock + no vaginal bleeding-20%
Risk factors:
Polyhydramnios
Trauma to abdomen
Previous abruptio Smoking
Hypertension Crack cocaine usage
Pre-eclampsia Thrombophilia
IUGR Anticoagulant
Multiple gestation therapy
Placenta Praevia Placenta Abruptio
• For fetal:
CTG
• For maternal:
FBC
Coagulation screen
GXM 4 units
Catheterization (monitor urine output)
Urea and creatinine (renal failure)
• In this patient because she is already at term, delivery is
indicated
1. Vaginal delivery – cervix favourable or foetal death
- ARM + oxytocin augmentation
2. LSCS – usually indicated for foetal distress
- use prophylactic oxytocin infusion routinely in
these cases
• Before LSCS or Vaginal delivery, always correct
Hypovolaemia
DIVC
Ensure urine output >30ml/hr
Other causes
Q4:
One hour later :
Maternal condition unchanged from admission.
borderline tachycardia, BP satisfactory, uterus contract
3:10 min and remains tender.
CTG: appropriate beat to beat variability, no
decelerations.
Coagulation screens:
Hb - 8.4 g/dl,
platelets - 105x109 /l,
fibrinogen - 2.2 g/l,
APTT - 48 s,
PT - 14 s,
Fibrin degradation
product - 2.1 mg/ml
Comment on these result
and discuss further
management
Results Interpretation Impression
Hb 8.4g/dl Low Anaemia
(11-16g/dl)
Platelets 105x109 /l Low
(150-400x109/l)
Fibrinogen 2.2 g/l Borderline low
Disseminated
(2-4 g/dl)
Intravascular
aPTT 48s Prolonged Coagulation(DIVC)
(35-45s)
pT 14s normal
(12-15s)
Fibrin degradation 2.1mg/ml Raised
products (<1mg/ml)
DIC
Secondary phenomenon following trigger of
generalised coagulation activity
Why?
• Retroplacenta blood clot
– Consumptive coagulopathy
– Hypofibrinogenemia
• Increase pressure within uterus (bp)
• Release of thromboplastin from circulation
/retroplacenta clot
management